HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

William Lauder To Carry On Family Tradition As Estee Lauder CEO

This article was originally published in The Rose Sheet

Executive Summary

Incoming Estee Lauder Chief Executive Officer William Lauder will concentrate efforts on building the company's brands in emerging markets, while continuing the growth initiatives implemented by CEO Fred Langhammer, the exec said

You may also be interested in...



Estee Lauder Appoints Group President Brestle Chief Operating Officer

Estee Lauder's management structure evolution continues under new President and CEO William Lauder with the appointment of Specialty Products Group President Dan Brestle to chief operating officer, with additional responsibilities that include research and development and select beauty brands

Estee Lauder Appoints Group President Brestle Chief Operating Officer

Estee Lauder's management structure evolution continues under new President and CEO William Lauder with the appointment of Specialty Products Group President Dan Brestle to chief operating officer, with additional responsibilities that include research and development and select beauty brands

Lauder Management Changes To Drive Growth, Build Brands

Estee Lauder announced a senior management shift at the firm Oct. 29 aimed at exploring new strategic initiatives, with current Group President of Estee Lauder, MAC and Aramis& Designer Fragrances Patrick Bousquet-Chavanne and MAC President John Demsey taking on new roles

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011811

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel